Project Details
| Status | Active |
|---|---|
| Effective start/end date | 09/11/23 → 05/26/27 |
Funding
- Amgen Incorporated: $224,142.00
A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Assessing the Impact of Olpasiran on Major Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein (a)
- Chen, On (PI)
- Rahman, Tahmid (CoPI)
- Skopicki, Hal A (CoPI)
Project: Research